Ocular and/or palpebral pruritus and/or ocular and/or palpebral pain and/or ocular and/or palpebral dysaesthesia afflicting a mammalian, notably human patient, are therapeutically treated by administering to such patient a therapeutically/cosmetically effective amount of at least one CGRP antagonist, advantageously in combinatory immixture with at least one antagonist of a neuropeptide other than CGRP, e.g., a substance P antagonist, and/or at least one inflammation mediator antagonist; the subject compositions are also well suited for making up and/or caring for human eyes, eyelashes and/or eyelids, especially sensitive eyes and eyelids.

O pruritus ocular e/ou palpebral e/ou a dor ocular e/ou palpebral e/ou o dysaesthesia ocular e/ou palpebral que afflicting um paciente mammalian, notàvelmente humano, são tratados therapeutically administrando a tal paciente um uma quantidade eficaz de therapeutically/cosmetically ao menos de um antagonista de CGRP, vantajosamente no immixture combinatory com ao menos o um antagonista de um neuropeptide à excepção de CGRP, por exemplo, um antagonista da substância P, e/ou ao menos um antagonista do mediator do inflammation; as composições sujeitas são também boas servidas fazendo acima e/ou importando-se com os olhos humanos, os eyelashes e/ou os eyelids, especial os olhos e os eyelids sensíveis.